Vera Therapeutics Inc (NASDAQ: VERA) on Monday, soared 4.02% from the previous trading day, before settling in for the closing price of $22.65. Within the past 52 weeks, VERA’s price has moved between $18.53 and $51.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 4.49% over the last five years. The company achieved an average annual earnings per share of -19.07%. With a float of $45.63 million, this company’s outstanding shares have now reached $63.77 million.
The firm has a total of 112 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vera Therapeutics Inc (VERA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vera Therapeutics Inc is 28.45%, while institutional ownership is 90.09%. The most recent insider transaction that took place on Jun 23 ’25, was worth 4,369,676. In this transaction Director of this company bought 209,393 shares at a rate of $20.87, taking the stock ownership to the 3,569,522 shares. Before that another transaction happened on Jun 24 ’25, when Company’s Director bought 40,607 for $22.35, making the entire transaction worth $907,635. This insider now owns 3,596,593 shares in total.
Vera Therapeutics Inc (VERA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -19.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.74% during the next five years compared to 4.49% growth over the previous five years of trading.
Vera Therapeutics Inc (NASDAQ: VERA) Trading Performance Indicators
Vera Therapeutics Inc (VERA) is currently performing well based on its current performance indicators. A quick ratio of 27.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.00, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -3.42 in one year’s time.
Technical Analysis of Vera Therapeutics Inc (VERA)
Analysing the last 5-days average volume posted by the [Vera Therapeutics Inc, VERA], we can find that recorded value of 1.94 million was better than the volume posted last year of 1.34 million. As of the previous 9 days, the stock’s Stochastic %D was 56.73%.
During the past 100 days, Vera Therapeutics Inc’s (VERA) raw stochastic average was set at 24.68%, which indicates a significant decrease from 64.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.13% in the past 14 days, which was lower than the 118.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.70, while its 200-day Moving Average is $33.71. Now, the first resistance to watch is $23.98. This is followed by the second major resistance level at $24.40. The third major resistance level sits at $25.14. If the price goes on to break the first support level at $22.81, it is likely to go to the next support level at $22.07. Should the price break the second support level, the third support level stands at $21.65.
Vera Therapeutics Inc (NASDAQ: VERA) Key Stats
Market capitalization of the company is 1.50 billion based on 63,774K outstanding shares. Right now, sales total 0 K and income totals -152,150 K. The company made 0 K in profit during its latest quarter, and -51,690 K in sales during its previous quarter.
